Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 17, 2016

View Archived Issues

Clinical safety and pharmacodynamics of VLX-103 in cirrhotic patients with early-stage HCC

Promising clinical data for TS-23 supports future development in thrombotic vascular diseases

FDA grants orphan drug designation to Genexine's GX-H9

Imara doses first volunteer in IMR-687 phase I trial

ALD-1910 induces photophobia in WT CT1 mice

Sorrento's TNK Therapeutics signs binding term sheet to acquire Virttu Biologics

EMA grants PRIME to SAGE-547 for postpartum depression

Genexine signs agreement with Merck & Co.

Cuvitru now available in U.S. for patients with primary immunodeficiency

LLS commits USD 40.3 million to fund new research into hematologic cancers

AstraZeneca announces completion of MEDI-2070 outlicensing agreement with Allergan

GTx to advance enobosarm phase II trial to final stage

Grunenthal acquires Thar Pharmaceutical

Tianjin Institute of Pharmaceutical Research patents URAT1 inhibitors

FDA grants fast track designation to crenolanib for GIST

Concert Pharmaceuticals discloses OTX-015 analogues

Daewoong Pharmaceutical describes ATPase inhibitors and/or 5-HT2A and/or M1 and/or M2 antagonists

Agilis Biotherapeutics treats first patient in phase IIb study of AGIL-AADC

Novartis reports promising topline results from STRIVE trial of AMG-334 in episodic migraine

Japanese researchers develop antimalarial agents

Chinese scientists present FXR agonists

Gilead reports topline results from phase III trials of momelotinib in myelofibrosis

Antidepressant effects of SUVN-1507035 in animal models of psychosis

CTC biomarker identifies CRPC patients likely to respond to PARP inhibitor treatment

Sofosbuvir, ledipasvir and ribavirin give high cure rates in drug users with hepatitis C

DSMB recommends continuation of phase III study of PXT-003 for CMT1A

Pfizer initiates phase I trial of PF-06747143 in AML

CD40L-encoding adenovirus enhances dendritic cell therapy for cancer

EMA grants positive opinion for teriparatide biosimilar

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...